![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Research Papers
Department of Cell Biology, Vanderbilt University, School of Medicine, Nashville, Tennessee 37232-2175.
Abstract
The myc proto-oncogene family has been implicated in multiple cellular processes, including proliferation, differentiation, and apoptosis. The Myc proteins, as heterodimers with Max protein, have been shown to function as activators of transcription through an E-box DNA-binding element, CACGTG. We have now found that the c-Myc proteins regulate transcription through another, noncanonical, DNA sequence. The non-AUG-initiated form of the c-Myc protein, c-Myc 1, strongly and specifically activates transcription of the C/EBP sequences within the EFII enhancer element of the Rous sarcoma virus long terminal repeat. In contrast, comparable amounts of the AUG-initiated form, c-Myc 2, fail to significantly affect enhancer activity. However, both c-Myc proteins trans-activate the CACGTG sequence comparably. In addition, Myc/Max heterodimers, but not Max homodimers, bind to the EFII enhancer sequence in vitro. Finally, c-Myc 1 overexpression, but not c-Myc 2 overexpression, significantly inhibits cell growth. These results reveal new transcriptional activities for the Myc proteins and demonstrate that the different forms of the Myc protein are functionally distinct. These results also suggest an interplay between two different growth regulatory transcription factor families.
CiteULike 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
|
|
 |
|
  C. Benassayag, L. Montero, N. Colombie, P. Gallant, D. Cribbs, and D. Morello Human c-Myc Isoforms Differentially Regulate Cell Growth and Apoptosis in Drosophila melanogaster Mol. Cell. Biol., November 15, 2005; 25(22): 9897 - 9909. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Bornes, M. Boulard, C. Hieblot, C. Zanibellato, J. S. Iacovoni, H. Prats, and C. Touriol Control of the Vascular Endothelial Growth Factor Internal Ribosome Entry Site (IRES) Activity and Translation Initiation by Alternatively Spliced Coding Sequences J. Biol. Chem., April 30, 2004; 279(18): 18717 - 18726. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. A. Gregory, Y. Qi, and S. R. Hann Phosphorylation by Glycogen Synthase Kinase-3 Controls c-Myc Proteolysis and Subnuclear Localization J. Biol. Chem., December 19, 2003; 278(51): 51606 - 51612. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Yang, J. R. Dunlap, R. B. Andrews, and R. Wetzel Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells Hum. Mol. Genet., November 1, 2002; 11(23): 2905 - 2917. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. R. Widlund, M. A. Horstmann, E. R. Price, J. Cui, S. L. Lessnick, M. Wu, X. He, and D. E. Fisher {beta}-Catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor J. Cell Biol., September 16, 2002; 158(6): 1079 - 1087. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Huez, S. Bornes, D. Bresson, L. Creancier, and H. Prats New Vascular Endothelial Growth Factor Isoform Generated by Internal Ribosome Entry Site-Driven CUG Translation Initiation Mol. Endocrinol., December 1, 2001; 15(12): 2197 - 2210. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. F. Claassen and S. R. Hann A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest PNAS, July 30, 2000; (2000) 150006697. [Abstract] [Full Text]
|
|
|
|
|
|
M. R. Adams, R. Sears, F. Nuckolls, G. Leone, and J. R. Nevins Complex Transcriptional Regulatory Mechanisms Control Expression of the E2F3 Locus Mol. Cell. Biol., May 15, 2000; 20(10): 3633 - 3639. [Abstract] [Full Text]
|
|
|
|
|
|
M. A. Gregory and S. R. Hann c-Myc Proteolysis by the Ubiquitin-Proteasome Pathway: Stabilization of c-Myc in Burkitt's Lymphoma Cells Mol. Cell. Biol., April 1, 2000; 20(7): 2423 - 2435. [Abstract] [Full Text]
|
|
|
|
|
|
A. Subramanian and D. M. Miller Structural Analysis of alpha -Enolase. MAPPING THE FUNCTIONAL DOMAINS INVOLVED IN DOWN-REGULATION OF THE c-myc PROTOONCOGENE J. Biol. Chem., February 25, 2000; 275(8): 5958 - 5965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Boyd and P. J. Farnham Coexamination of Site-Specific Transcription Factor Binding and Promoter Activity in Living Cells Mol. Cell. Biol., December 1, 1999; 19(12): 8393 - 8399. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. E. Boyd and P. J. Farnham Identification of Target Genes of Oncogenic Transcription Factors Experimental Biology and Medicine, October 2, 1999; 222(1): 9 - 28. [Abstract] [Full Text]
|
|
|
|
|
|
C. V. Dang c-Myc Target Genes Involved in Cell Growth, Apoptosis, and Metabolism Mol. Cell. Biol., January 1, 1999; 19(1): 1 - 11. [Full Text] [PDF]
|
|
|
|
|
|
E. Arnaud, C. Touriol, C. Boutonnet, M.-C. Gensac, S. Vagner, H. Prats, and A.-C. Prats A New 34-Kilodalton Isoform of Human Fibroblast Growth Factor 2 Is Cap Dependently Synthesized by Using a Non-AUG Start Codon and Behaves as a Survival Factor Mol. Cell. Biol., January 1, 1999; 19(1): 505 - 514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Xiao, G. Claassen, J. Shi, S. Adachi, J. Sedivy, and S. R. Hann Transactivation-defective c-MycS retains the ability to regulate proliferation and apoptosis Genes & Dev., December 15, 1998; 12(24): 3803 - 3808. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Malyak, J. M. Guthridge, K. R. Hance, S. K. Dower, J. H. Freed, and W. P. Arend Characterization of a Low Molecular Weight Isoform of IL-1 Receptor Antagonist J. Immunol., August 15, 1998; 161(4): 1997 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Batsché, C. Muchardt, J. Behrens, H. C. Hurst, and C. Crémisi RB and c-Myc Activate Expression of the E-Cadherin Gene in Epithelial Cells through Interaction with Transcription Factor AP-2 Mol. Cell. Biol., July 1, 1998; 18(7): 3647 - 3658. [Abstract] [Full Text]
|
|
|
|
 |
|
 L. Facchini and L. Z. Penn The molecular role of Myc in growth and transformation: recent discoveries lead to new insights FASEB J, June 1, 1998; 12(9): 633 - 651. [Abstract] [Full Text]
|
|
|
|
 |
|
 M. Wu, R. E. Bellas, J. Shen, and G. E. Sonenshein Roles of the Tumor Suppressor p53 and the Cyclin-dependent Kinase Inhibitor p21WAF1/CIP1 in Receptor-mediated Apoptosis of WEHI 231 B Lymphoma Cells J. Exp. Med., May 18, 1998; 187(10): 1671 - 1679. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Nanbru, I. Lafon, S. Audigier, M.-C. Gensac, S. Vagner, G. Huez, and A.-C. Prats Alternative Translation of the Proto-oncogene c-myc by an Internal Ribosome Entry Site J. Biol. Chem., December 19, 1997; 272(51): 32061 - 32066. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Gandarillas and F. M. Watt c-Myc promotes differentiation of human epidermal stem cells Genes & Dev., November 1, 1997; 11(21): 2869 - 2882. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. D. Siebert and B. C. B. Huang Identification of an alternative form of human lactoferrin mRNA that is expressed differentially in normal tissues and tumor-derived cell lines PNAS, March 18, 1997; 94(6): 2198 - 2203. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Hsieh-Li, D. Witte, M Weinstein, W Branford, H Li, K Small, and S. Potter Hoxa 11 structure, extensive antisense transcription, and function in male and female fertility Development, January 5, 1995; 121(5): 1373 - 1385. [Abstract] [PDF]
|
|
|
|
|
|
G. F. Claassen and S. R. Hann A role for transcriptional repression of p21CIP1 by c-Myc in overcoming transforming growth factor beta -induced cell-cycle arrest PNAS, August 15, 2000; 97(17): 9498 - 9503. [Abstract] [Full Text] [PDF]
|
|
